ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
LightRoseTTA: High-Efficient and Accurate Protein Structure Prediction Using a Light-Weight Deep Graph Model.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- LightRoseTTA: High-Efficient and Accurate Protein Structure Prediction Using a Light-Weight Deep Graph Model.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurately predicting protein structure, from sequences to 3D structures, is of great significance in biological research. To tackle this issue, a representative deep big model, RoseTTAFold, is proposed with promising success. Here, "a light-weight deep graph network, named LightRoseTTA," is reported to achieve accurate and highly efficient prediction for proteins. Notably, three highlights are possessed by LightRoseTTA: i) high-accurate structure prediction for proteins, being "competitive with RoseTTAFold" on multiple popular datasets including CASP14 and CAMEO; ii) high-efficient training and inference with a light-weight model, costing "only 1 week on one single NVIDIA 3090 GPU for model-training" (vs 30 days on 8 NVIDIA V100 GPUs for RoseTTAFold) and containing "only 1.4M parameters" (vs 130M in RoseTTAFold); iii) low dependency on multi-sequence alignment (MSA), achieving the best performance on three MSA-insufficient datasets: Orphan, De novo, and Orphan25. Besides, LightRoseTTA is "transferable" from general proteins to antibody data, as verified in the experiments. The time and resource costs of LightRoseTTA and RoseTTAFold are further discussed to demonstrate the feasibility of light-weight models for protein structure prediction, which may be crucial in resource-limited research for universities and academic institutions. The code and model are released to speed biological research (https://github.com/psp3dcg/LightRoseTTA).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.